News

InnovAge Holding Corp. (INNV) Q2 2025 Earnings Call Transcript

1 Mins read

InnovAge Holding Corp. (NASDAQ:INNV) Q2 2025 Results Earnings Conference Call February 4, 2025 5:00 PM ET

Company Participants

Ryan Kubota – Director of Investor Relations
Patrick Blair – Chief Executive Officer
Ben Adams – Chief Financial Officer
Richard Feifer – Chief Medical Officer

Conference Call Participants

Jamie Perse – Goldman Sachs
Jared Haase – William Blair
Matthew Gilmore – KeyBanc Capital Markets
Benjamin Rossi – J.P. Morgan

Operator

Welcome to InnovAge Second Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Ryan Kubota, Director of Investor Relations. Please go ahead.

Ryan Kubota

Thank you, operator. Good afternoon. Thank you all for joining the InnovAge 2025 Fiscal Second Quarter Earnings Call. With me today is Patrick Blair, CEO, and Ben Adams, CFO. Michael Scarborough, President and COO, and Dr. Rich Feifer, Chief Medical Officer, will also be joining the Q&A portion of the call.

Today, after the market closed, we issued an earnings press release containing detailed information on our fiscal second quarter results. You may access the release on the investor relations section of our company website, innovage.com.

For those listening to the rebroadcast of this call, we remind you that the remarks made herein are as of today, Tuesday, February 4th, 2025, and have not been updated subsequent to this call.

During our call, we refer to certain non-GAAP measures. Reconciliation of these measures to the most directly comparable GAAP measures can be found in our earnings press release posted on our website.

We will also be making forward-looking statements, including statements related to our 2025 fiscal year projections and

Read the full article here

Related posts
News

Halozyme Therapeutics, Inc. (HALO) Discusses to Acquire ElektrofiConferenceCallTranscript

1 Mins read
Follow Play Earnings CallPlay Earnings Call Halozyme Therapeutics, Inc. (NASDAQ:HALO) Halozyme to Acquire Elektrofi Conference Call October 1, 2025 8:30 AM EDT…
News

Australian Foundation Investment Co (AFOVF) Shareholder/Analyst Call Transcript

1 Mins read
Company Participants Craig DrummondRobert Freeman – MD, CEO & DirectorDavid PeeverMatthew Rowe – Company SecretaryAndrew J. Porter – CFO & Company SecretaryGeoffrey…
News

Unilever: Strong Brands But Fragile Financials – Why I’m Bearish (NYSE:UL)

1 Mins read
This article was written by Follow I am a UK-based equity enthusiast and private investor with a professional background in finance. With…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *